NEW YORK--(BUSINESS WIRE)--Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases, announced today that Gary S. Jacob, Ph.D., Chief Executive Officer of Callisto Pharmaceuticals will present a company update at the BIO InvestorForum 2007 which is being held on October 9-11, 2007 at the Palace Hotel in San Francisco. Dr. Jacob’s presentation will be on Thursday October 11, 2007, at 3pm in the Telegraph room at the Palace Hotel.
